Why Your Prescribed Dose May Not Be Right for You — And How to Raise the Conversation

When a physician writes a prescription, they are drawing on clinical guidelines, package insert recommendations, and their own experience — all of which are grounded in population-level data. That data was gathered from clinical trial participants who may look very little like you. They may have been younger, healthier, predominantly male (a longstanding and well-documented bias in pharmaceutical research), or simply different in ways that matter biochemically. The dose printed on your prescription bottle is, at best, an educated starting point.

This is not a criticism of your physician. It is simply the reality of how drug dosing is established and how medicine is practiced at scale. Understanding this reality — and knowing when and how to advocate for a dosage review — is one of the most practical things a medication-aware patient can do.

How Standard Doses Are Determined

Pharmaceutical dosing recommendations emerge from a staged process. During Phase I clinical trials, researchers establish a drug's basic safety profile and identify a preliminary dose range in a small group of volunteers. Phase II and Phase III trials refine that range across larger populations, identifying the dose that produces the desired therapeutic effect in the majority of participants without unacceptable side effects.

The operative phrase is "the majority of participants." Clinical trials are designed to find a dose that works reasonably well for a statistically representative sample — not to identify the optimal dose for every individual subgroup within that sample. The result is a prescribing recommendation that functions well as a population-level default but may require individualization for patients whose characteristics fall outside the center of the distribution.

Four biological factors account for the largest share of clinically meaningful dosing variability:

Kidney Function

The kidneys are responsible for filtering and eliminating a large number of medications and their metabolites from the body. When kidney function is reduced — whether due to chronic kidney disease, acute illness, or the natural decline that accompanies aging — drugs that are renally cleared can accumulate to higher-than-intended concentrations. Medications including metformin, gabapentin, many antibiotics, and certain blood pressure drugs require dose adjustments when kidney function falls below established thresholds.

A standard creatinine blood test and the calculated eGFR (estimated glomerular filtration rate) that typically accompanies it give your physician the information needed to make this adjustment. The concern is that these values are not always checked before prescribing, or are not revisited when a patient's kidney function changes over time.

Liver Function

The liver metabolizes the majority of medications through a family of enzymes known as the cytochrome P450 system. Patients with hepatic impairment — from conditions such as cirrhosis, hepatitis, or significant alcohol use — may metabolize certain drugs more slowly, leading to elevated drug levels. Conversely, some individuals carry genetic variants that cause them to metabolize specific drugs either far faster or far slower than average. This pharmacogenomic dimension of dosing is an emerging area of clinical medicine, and genetic testing to guide medication selection and dosing is increasingly available, though not yet universally integrated into standard care.

Body Weight and Composition

Many medications are dosed on a one-size-fits-all basis despite evidence that body weight influences drug distribution, particularly for lipid-soluble drugs that distribute into fatty tissue. Pediatric dosing is almost universally weight-based, yet adult dosing frequently defaults to a fixed amount regardless of whether the patient weighs 130 pounds or 280 pounds. For certain medications — some chemotherapy agents, specific antibiotics, and low-molecular-weight heparins among them — weight-based dosing in adults is standard practice. For many others, it arguably should be.

Drug Interactions

The average Medicare beneficiary takes five or more prescription medications. Polypharmacy — the concurrent use of multiple drugs — creates a complex pharmacological environment in which one medication can meaningfully alter the absorption, distribution, metabolism, or elimination of another. Some interactions increase drug concentrations to potentially toxic levels; others reduce them below the therapeutic threshold, rendering treatment ineffective. A patient who begins a new prescription without a comprehensive review of their existing medication list is navigating that environment without a map.

Recognizing the Signs That Your Dose May Need Review

Patients often attribute suboptimal drug responses to the underlying condition rather than to the dose. The following scenarios warrant a dosage conversation with your prescriber or pharmacist:

Persistent symptoms despite adherence. If you are taking your medication consistently and your condition remains inadequately controlled, the dose may be insufficient for your individual pharmacokinetics. This is particularly relevant for medications used to manage chronic conditions such as hypertension, depression, hypothyroidism, and type 2 diabetes.

Side effects that seem disproportionate. Experiencing side effects that feel more intense than those described in the prescribing information — or that your physician characterized as unlikely at the prescribed dose — may indicate that the drug is accumulating at higher-than-expected levels in your system.

A recent change in your health status. The development or progression of kidney disease, liver disease, heart failure, or significant unintentional weight loss can alter how your body handles medications you have been taking for years without incident. A drug that was appropriately dosed at 60 years old may need recalibration at 72.

A new prescription added to your regimen. Every time a new medication enters your routine, the potential for interaction with existing prescriptions should be evaluated. This review should happen proactively, not after a problem emerges.

Switching between formulations. Moving from an immediate-release to an extended-release formulation, or vice versa, is not always a straightforward milligram-for-milligram conversion. The same is true of switching between certain delivery routes — oral to transdermal, for example.

How to Have This Conversation Effectively

Many patients hesitate to raise dosing concerns with their physicians, fearing they will appear to be second-guessing clinical expertise. This hesitation is understandable but counterproductive. Physicians have limited appointment time and cannot always proactively monitor every variable that might affect your dosing needs. Your observations about your own response to a medication are clinical data.

Approach the conversation with specificity rather than generality. Rather than stating that a medication "doesn't seem to be working," describe the specific symptoms that remain uncontrolled, their frequency, and their severity. If you suspect a side effect is dose-related, keep a brief log of when symptoms occur relative to when you take the medication. Bring a complete list of every medication, supplement, and over-the-counter product you take — this list is foundational to any meaningful dosing review.

Practical questions worth raising include:

• Was my kidney or liver function considered when this dose was selected?
• Does my weight or age affect how this drug should be dosed?
• Are any of my other medications known to interact with this one?
• What signs should prompt me to call you before my next scheduled appointment?

Your pharmacist is also a deeply underutilized resource in this context. Pharmacists are specifically trained in pharmacokinetics and drug interactions, and a comprehensive medication review with your pharmacist — a service many independent pharmacies and chain pharmacies offer — can surface concerns that busy prescribing appointments sometimes miss.

The Goal Is Precision, Not Perfection

Dosage individualization is not about finding fault with your physician's initial prescription. It is about recognizing that medication management is an ongoing, dynamic process rather than a one-time decision. The right dose for you today may not be the right dose for you in three years. Staying engaged with that process — asking questions, reporting your experience accurately, and understanding the biological factors that influence your response to medication — is among the most consequential things you can do for your long-term health.